Candel Therapeutics, Inc.
USD10.22
+0.65 (+6.79%)
CEO
Paul-Peter Tak
IPO Date
2021-07-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.75
Prev. Close
$9.57
Day Low
$9.68
Day High
$10.29
52W Low
$4.35
52W High
$11.36
Market Cap
$0.56B
Volume
1.27M
| -5.0 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -297.7% | -92.1% | 1.79 | 2.59 | -1.1 |
| 31 Dec 2022 | FY | 100.0% | -15035.2% | -39.4% | -23.9% | 0.48 | 12.81 | -2.7 |
| 31 Dec 2021 | FY | 100.0% | -28899.2% | -56.3% | -40.5% | 0.01 | 15.84 | -6.2 |
| 31 Dec 2020 | FY | 100.0% | -14144.0% | 75.0% | -46.2% | -0.04 | 7.46 | -7.4 |
| 31 Dec 2019 | FY | 100.0% | -6592.0% | 102.5% | -18.0% | -0.05 | 32.06 | -15.9 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -14.1% | -12.0% | 0.08 | 8.25 | -6.2 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -5.3% | -4.5% | 0.09 | 7.04 | -13.6 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 9.9% | 7.7% | 0.15 | 4.64 | 6.1 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -21.2% | -13.2% | 0.20 | 2.77 | -5.5 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | 69.8% | -49.5% | -1.09 | 1.18 | -5.2 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 223.0% | -84.0% | -1.92 | 1.62 | -2.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -137.5% | -26.3% | 3.53 | 2.00 | -1.6 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -87.1% | -26.6% | 1.79 | 2.59 | -1.0 |